Page last updated: 2024-08-23

rafoxanide and Liver Neoplasms

rafoxanide has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hou, CY; Huang, CL; Lin, YJ; Ma, CY; Wang, HD; Yuh, CH1

Other Studies

1 other study(ies) available for rafoxanide and Liver Neoplasms

ArticleYear
WNK1-OSR1 Signaling Regulates Angiogenesis-Mediated Metastasis towards Developing a Combinatorial Anti-Cancer Strategy.
    International journal of molecular sciences, 2022, Oct-11, Volume: 23, Issue:20

    Topics: Animals; beta-Galactosidase; Carcinoma, Hepatocellular; Human Umbilical Vein Endothelial Cells; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Lysine; Minor Histocompatibility Antigens; Neovascularization, Pathologic; Protein Phosphatase 2; Protein Serine-Threonine Kinases; Rafoxanide; Transcription Factors; Tumor Suppressor Protein p53; WNK Lysine-Deficient Protein Kinase 1; Zebrafish

2022